Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Coy NN, Ashcroft AJ, Drayson MT, Owen RG, Jackson GH, Child JA

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Bone: 10th International Conference on Cancer - Induced Bone Disease

Year of Conference: 2011

Pages: S16-S17

ISSN: 8756-3282

Publisher: Elsevier Inc.

URL: http://dx.doi.org/10.1016/j.bone.2010.10.043

DOI: 10.1016/j.bone.2010.10.043

Library holdings: Search Newcastle University Library for this item

ISBN: 18732763

ePrints